<DOC>
	<DOCNO>NCT00221390</DOCNO>
	<brief_summary>The purpose study ass efficacy , well safety , Ropinirole improve movement among patient chronic stroke .</brief_summary>
	<brief_title>Trial Ropinirole Motor Recovery After Stroke</brief_title>
	<detailed_description>Stroke lead cause disability . Current treatment target injury must deliver within hour . A body literature suggest process ongoing days-months stroke target therapeutically , improve function . The current study evaluate one potential therapy , dopamine agonist ropinirole . The current study test hypothesis patient chronic stroke randomized ropinirole+physiotherapy show improve gait velocity 12 week study participation compare patient randomize placebo+physiotherapy . A secondary aim test hypothesis ropinirole improve three secondary endpoint 12 week study entry : proportion patient significant disability ( Barthel Index â‰¥ 95 ) ; overall motor status , measure arm/leg FM score ; overall physical function , define score Stroke Impact Scale-16 ( SIS-16 ) . This study also evaluate safety ropinirole patient recover stroke .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Paresis</mesh_term>
	<mesh_term>Ropinirole</mesh_term>
	<criteria>1 . Stroke onset 4 weeks12 month prior 2 . Stroke radiologically confirm either ( ) ischemic ( b ) hemorrhagic 3 . Minimum age 18 4 . No significant prestroke disability 5 . No stroke previous 3 month 6 . Absence major depression 7 . FuglMeyer ( FM ) motor score 2383 100 8 . Functional Independence Measure ( FIM ) ambulationsubscore 3 , 50 foot walk take longer 15 second 1 . Significant daytime somnolence substantial decrease alertness , language reception , attention 2 . Pregnant lactate 3 . Advanced liver , kidney , cardiac , pulmonary disease 4 . Orthostatic hypotension 5 . Current use ciprofloxacin , centrally act dopamine agonist , centrally active dopamine antagonist 6 . A terminal medical diagnosis consistent survival &lt; 1 year 7 . Coexistent major neurological disease 8 . Coexistent major psychiatric disease 9 . A history significant alcohol drug abuse prior 3 year 10 . A coexistent disease characterize abnormality CNS dopaminergic tone 11 . Current enrollment another investigational study relate stroke stroke recovery 12 . Contraindication ropinirole prescription</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>stroke</keyword>
	<keyword>Chronic stroke hemiparesis</keyword>
</DOC>